A 9-year-old child is admitted with high fever, vomiting, photophobia, and neck rigidity. Cerebrospinal fluid analysis confirms pneumococcal meningitis. Public health surveillance confirms that there have been no other similar infections reported locally in the last month.
What is the most appropriate approach for managing the child’s household and close contacts?
A. Provide reassurance only, without medication
B. Give a single dose of oral fluoroquinolone to all contacts
C. Prescribe a short course of oral beta-lactam antibiotics
D. Administer a booster dose of pneumococcal conjugate vaccine to contacts
E. Combine oral antibiotics with pneumococcal vaccination for contacts
—
Answer
A. Provide reassurance only, without medication
—
Detailed discussion for MRCP
Pneumococcal meningitis is caused by Streptococcus pneumoniae, an encapsulated gram-positive diplococcus that commonly colonises the nasopharynx of healthy individuals, especially children. Asymptomatic carriage rates are high, often exceeding 40–60% in young children, which is fundamentally different from Neisseria meningitidis.
Because pneumococcal carriage is common and usually benign, secondary transmission leading to invasive disease among close contacts is rare. Therefore, unlike meningococcal meningitis, routine antibiotic chemoprophylaxis is not recommended for household or close contacts of a single sporadic case of pneumococcal meningitis.
Public health authorities (including UK Health Security Agency, formerly HPA) advise that no action is needed for contacts unless there is evidence of a cluster or outbreak, such as:
Two or more confirmed pneumococcal meningitis cases in a defined setting (e.g. household, nursery, school)
Cases occurring within a short time frame
Involvement of an unusual or highly invasive pneumococcal serotype
In outbreak situations, public health teams may consider targeted antibiotic prophylaxis and/or vaccination, but this is rare and protocol-driven.
This contrasts sharply with meningococcal disease, where close contacts have a significantly increased risk of invasive disease, particularly in the first 7 days, and therefore require urgent chemoprophylaxis (usually single-dose ciprofloxacin) and often vaccination.
From an MRCP perspective, a key exam trap is offering ciprofloxacin prophylaxis for all bacterial meningitis. This is incorrect. Only meningococcal meningitis routinely requires contact prophylaxis.
Another high-yield point: pneumococcal vaccination status of contacts does not change acute management. Vaccination is a preventive population-level strategy, not a post-exposure intervention in sporadic cases.
Also remember that pneumococcal meningitis carries a higher mortality and risk of neurological sequelae than meningococcal disease, which is why early IV antibiotics and adjunctive dexamethasone are crucial for the patient—but this does not translate into contact management.
—
Cheat sheet (exam-focused)
Pneumococcal meningitis → no routine prophylaxis for contacts
Pneumococcus = common nasopharyngeal commensal
Secondary transmission risk = low
Prophylaxis only if cluster/outbreak
Meningococcal meningitis → prophylaxis always needed
Drug of choice for meningococcal contacts: single-dose ciprofloxacin
Vaccination of contacts ≠ routine post-exposure measure for pneumococcus
High carriage ≠ high invasive disease risk
Public health teams manage clusters, not clinicians individually
MRCP pitfall: giving ciprofloxacin for pneumococcal exposure
—
Flash cards
1. Q: Common cause of bacterial meningitis in adults?
A: Streptococcus pneumoniae
Explanation: Most frequent cause with high mortality.
2. Q: Nasopharyngeal carriage rate of pneumococcus?
A: Very high, especially in children
Explanation: Explains lack of need for prophylaxis.
3. Q: Do contacts of pneumococcal meningitis need antibiotics?
A: No
Explanation: Transmission risk is low.
4. Q: Organism requiring routine contact prophylaxis?
A: Neisseria meningitidis
Explanation: High secondary attack rate.
5. Q: Drug of choice for meningococcal prophylaxis?
A: Oral ciprofloxacin
Explanation: Single dose, effective, widely available.
6. Q: Time window of highest risk for meningococcal contacts?
A: First 7 days
Explanation: But risk persists up to 4 weeks.
7. Q: Is pneumococcal vaccine given as post-exposure prophylaxis?
A: No
Explanation: Preventive, not reactive.
8. Q: What changes management for pneumococcal contacts?
A: Cluster of cases
Explanation: Managed by public health.
9. Q: Mortality comparison: pneumococcal vs meningococcal meningitis?
A: Higher in pneumococcal
Explanation: Despite lower transmission.
10. Q: Capsule importance in pneumococcus?
A: Virulence factor
Explanation: Helps evade phagocytosis.
11. Q: Is chemoprophylaxis based on organism or severity?
A: Organism
Explanation: Severity does not determine contact management.
12. Q: Common MRCP error in meningitis questions?
A: Over-prescribing ciprofloxacin
Explanation: Only for meningococcal disease.
13. Q: Who decides on outbreak prophylaxis?
A: Public health authorities
Explanation: Not individual clinicians.
14. Q: Does close contact include casual classroom exposure for pneumococcus?
A: No
Explanation: No action needed.
15. Q: Antibiotic used for pneumococcal meningitis treatment?
A: IV ceftriaxone
Explanation: First-line.
16. Q: Adjunctive therapy in pneumococcal meningitis?
A: Dexamethasone
Explanation: Reduces neurological sequelae.
17. Q: Gram status of pneumococcus?
A: Gram-positive
Explanation: Diplococci.
18. Q: Shape of pneumococcus?
A: Lancet-shaped diplococci
Explanation: Classic exam description.
19. Q: Is rifampicin used for pneumococcal contacts?
A: No
Explanation: Used for meningococcal contacts.
20. Q: Key phrase in question pointing to “no action”?
A: No other local cases
Explanation: Indicates sporadic disease.
—
MCQs to test yourself
1. Close contacts of pneumococcal meningitis should usually receive:
A. Oral ciprofloxacin
B. Rifampicin for 2 days
C. No specific intervention
D. Pneumococcal vaccine immediately
E. Oral amoxicillin
Answer: C – Routine prophylaxis is not indicated
2. The main reason prophylaxis is not given for pneumococcal contacts is:
A. Antibiotic resistance
B. Low virulence
C. High asymptomatic carriage
D. Poor vaccine efficacy
E. Rapid symptom onset
Answer: C
3. Which organism mandates chemoprophylaxis for contacts?
A. Streptococcus pneumoniae
B. Haemophilus influenzae
C. Neisseria meningitidis
D. Listeria monocytogenes
E. Escherichia coli
Answer: C
4. Drug of choice for meningococcal contact prophylaxis is:
A. Amoxicillin
B. Ceftriaxone
C. Ciprofloxacin
D. Doxycycline
E. Azithromycin
Answer: C
5. Which of the following is false regarding pneumococcal meningitis?
A. It has high mortality
B. It commonly colonises the nasopharynx
C. Contacts need routine prophylaxis
D. Treated with ceftriaxone
E. Dexamethasone may be beneficial
Answer: C
6. A cluster of pneumococcal meningitis is best managed by:
A. GP
B. Emergency physician
C. Neurologist
D. Public health team
E. Microbiology lab alone
Answer: D
7. Pneumococcal vaccination of contacts after a single case is:
A. Mandatory
B. Recommended
C. Contraindicated
D. Usually unnecessary
E. Urgently required
Answer: D
8. Which feature most strongly suggests meningococcal rather than pneumococcal disease in contact management?
A. Neck stiffness
B. Rash
C. High fever
D. Nasal carriage
E. CSF neutrophilia
Answer: B
9. Which age group has highest pneumococcal carriage?
A. Elderly
B. Neonates
C. Teenagers
D. Young children
E. Adults
Answer: D
10. Which statement is false?
A. Pneumococcus is encapsulated
B. Pneumococcus is gram-positive
C. Pneumococcal contacts need ciprofloxacin
D. Pneumococcus causes severe meningitis
E. Carriage is common
Answer: C
11. Adjunctive dexamethasone is most useful in:
A. Viral meningitis
B. Tuberculous meningitis only
C. Pneumococcal meningitis
D. Fungal meningitis
E. Post-LP headache
Answer: C
12. Which factor would prompt reconsideration of prophylaxis for pneumococcal contacts?
A. Single case
B. Vaccinated child
C. Multiple linked cases
D. Severe disease
E. ICU admission
Answer: C
13. Public health notification is essential in:
A. All headaches
B. All meningitis cases
C. Only viral meningitis
D. Only fungal meningitis
E. Migraine with fever
Answer: B
14. Which organism has the highest secondary attack rate?
A. Pneumococcus
B. Listeria
C. Meningococcus
D. TB
E. HSV
Answer: C
15. Which of the following is false?
A. Pneumococcal carriage is common
B. Prophylaxis reduces pneumococcal spread
C. Outbreaks are rare
D. Management differs by organism
Answer: B
16. A single sporadic case of pneumococcal meningitis requires:
A. School closure
B. Household antibiotics
C. Reassurance only
D. Mass vaccination
E. Rifampicin
Answer: C
17. Which guideline body advises no routine pneumococcal prophylaxis?
A. NICE
B. BNF
C. UKHSA
D. All of the above
E. None
Answer: D
18. Which antibiotic is NOT used in meningococcal prophylaxis?
A. Ciprofloxacin
B. Rifampicin
C. Ceftriaxone
D. Amoxicillin
E. All may be used
Answer: D
19. Which feature differentiates pneumococcal from meningococcal contact management?
A. Mortality
B. Carriage rate
C. CSF findings
D. Need for prophylaxis
E. Incubation period
Answer: D
20. In exams, “no other local cases” most strongly implies:
A. Vaccinate contacts
B. Give ciprofloxacin
C. Do nothing for contacts
D. Start rifampicin
E. Repeat CSF
Answer: C
—
Summary for quick exam revision
Pneumococcal meningitis is a severe infection with high mortality, but because Streptococcus pneumoniae is commonly carried asymptomatically in the nasopharynx, the risk of secondary transmission to close contacts is low. As a result, routine antibiotic prophylaxis or vaccination of contacts is not recommended following a single sporadic case. This is in contrast to meningococcal meningitis, where close contacts are at significant risk and require urgent chemoprophylaxis, usually with single-dose oral ciprofloxacin, and often vaccination. Prophylaxis for pneumococcal contacts is only considered in rare situations involving clusters or outbreaks and is managed by public health authorities. For MRCP exams, the key discriminator is the causative organism, not disease severity, and the phrase “no other local cases” is a strong clue that no action is needed for contacts.